| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |